T1	Chemical	0 17	Both chemotherapy
T2	Gene_or_protein	22 54	epidermal growth factor receptor
T3	Chemical	22 81	epidermal growth factor receptor tyrosine kinase inhibitors
T4	Gene_or_protein	84 91	EGFR TK
T5	Chemical	84 99	EGFR TKIs ) are
T6	Disease	136 178	non-small cell lung cancer ( NSCLC ) , but
T7	Pharmacodynamic_phenotype	183 200	efficacy of these
R1	influences	Arg1:T1	Arg2:T4
R2	treats	Arg1:T1	Arg2:T6
R3	treats	Arg1:T1	Arg2:T7
R4	influences	Arg1:T2	Arg2:T1
R5	influences	Arg1:T2	Arg2:T3
R6	influences	Arg1:T2	Arg2:T4
R7	influences	Arg1:T2	Arg2:T5
R8	treats	Arg1:T2	Arg2:T6
R9	treats	Arg1:T2	Arg2:T7
R10	influences	Arg1:T3	Arg2:T1
R11	influences	Arg1:T3	Arg2:T2
R12	isEquivalentTo	Arg1:T3	Arg2:T4
R13	treats	Arg1:T3	Arg2:T6
R14	treats	Arg1:T3	Arg2:T7
R15	influences	Arg1:T4	Arg2:T1
R16	isEquivalentTo	Arg1:T4	Arg2:T2
R17	isEquivalentTo	Arg1:T4	Arg2:T3
R18	isEquivalentTo	Arg1:T4	Arg2:T5
R19	treats	Arg1:T4	Arg2:T6
R20	influences	Arg1:T5	Arg2:T1
R21	isEquivalentTo	Arg1:T5	Arg2:T2
R22	isEquivalentTo	Arg1:T5	Arg2:T3
R23	isEquivalentTo	Arg1:T5	Arg2:T4
R24	treats	Arg1:T5	Arg2:T6
R25	influences	Arg1:T7	Arg2:T1
R26	influences	Arg1:T7	Arg2:T2
R27	influences	Arg1:T7	Arg2:T3
R28	influences	Arg1:T7	Arg2:T4
R29	influences	Arg1:T7	Arg2:T5
R30	treats	Arg1:T7	Arg2:T6
